Bufexamac is a frequent contact sensitizer. 1996

B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
Department of Dermatology, University of Graz, Austria.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010328 Patch Tests Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction. Patch Testing,Patch Test,Patch Testings,Test, Patch,Testing, Patch,Testings, Patch,Tests, Patch
D002019 Bufexamac A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally. Allergipuran,Bufal,Bufederm,Bufexamac-ratiopharm,Droxaryl,Jomax,Malipuran,Paraderm,Parfenac,Windol,duradermal,p-Butoxyphenylacethydroxamic Acid,Bufexamac ratiopharm,Bufexamacratiopharm,p Butoxyphenylacethydroxamic Acid
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
September 1978, The British journal of dermatology,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
April 1989, Contact dermatitis,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
May 1982, Dermatologica,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
August 1975, Contact dermatitis,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
June 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
January 1973, Dermatologica,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
June 2022, Journal of the European Academy of Dermatology and Venereology : JEADV,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
May 1987, Contact dermatitis,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
September 1983, Contact dermatitis,
B Kränke, and J Derhaschnig, and P Komericki, and W Aberer
July 1989, Medizinische Klinik (Munich, Germany : 1983),
Copied contents to your clipboard!